Part VII transfer
Annuities are a capital-intensive business under Solvency II. We knew there was a competitive market, and saw an opportunity to de-risk. [Rothesay Life] was crystal clear about what it could and couldn’t do. It felt like they had thought everything through and showed real expertise on the risks of an insurance-to-insurance transfer under Solvency II.Stephen McGee, Aegon UK’s chief financial officer
- ‘Part VII transfer of £6.4bn of annuity policies to Rothesay Life involving 187,000 policy holders
- The first Solvency II-compliant transaction approved by the UK PRA setting precedents for transitional arrangements
- Significant amount of the longevity risk was reinsured pre-execution
- Economic terms were locked in by agreeing the premium upfront and then converting to roll forward to lock-in capital release and terms
- In September 2015, Aegon commenced a process to de-risk its UK annuity portfolio
- On 11 April 2016, Aegon announced the sale of two-thirds of its UK annuity portfolio to Rothesay Life, equivalent to a premium of £6.4bn
- The transaction was structured initially as a reinsurance contract pending the legal transfer process regulatory and court approvals
- The Part VII Transfer was approved at a Hearing of the High Court 13 June 2017 and became effective at 00.01am BST on 30 June 2017
Rothesay Life News
3 April 2019
Rothesay Life's 2018 Full Year Financial Results and Business Highlights
Today the company announces its audited results and business highlights for the year ending 31 December 2018.
2 April 2019
Rothesay Life agrees £110m bulk annuity deal with Laird Limited
Rothesay Life plc is pleased to announce it insured the defined benefit liabilities for the Laird Pension Scheme.
1 April 2019
Monument Re to acquire an Irish portfolio from Rothesay Life
Monument Re announced today that, subject to regulatory approval, it has entered into an agreement to acquire a portfolio of Irish annuities from Rothesay Life.